{{Rsnum
|rsid=460000
|Gene=SLC6A3
|Chromosome=5
|position=1432710
|Orientation=minus
|GMAF=0.3985
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=SLC6A3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 5.3 | 38.1 | 56.6
| HCB | 27.7 | 53.3 | 19.0
| JPT | 31.0 | 54.9 | 14.2
| YRI | 25.9 | 49.7 | 24.5
| ASW | 24.6 | 45.6 | 29.8
| CHB | 27.7 | 53.3 | 19.0
| CHD | 29.4 | 51.4 | 19.3
| GIH | 23.8 | 47.5 | 28.7
| LWK | 23.6 | 56.4 | 20.0
| MEX | 13.8 | 44.8 | 41.4
| MKK | 7.7 | 43.6 | 48.7
| TSI | 4.9 | 35.3 | 59.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=20091113
|Title=Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers
}}

{{PMID Auto
|PMID=19673036
|Title=Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population.
|OA=1
}}

{{PMID Auto
|PMID=21876545
|Title=Dopamine transporter genotype predicts behavioural and neural measures of response inhibition.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}